1 company-specific change
fiscal period 2025-12-31
filed 2026-02-12
- Environmental claims and litigation removed from risk factor. Company narrowed scope from asbestos AND environmental to asbestos only, suggesting reduced exposure or de-prioritization of environmental liability risk.
See the full detail →
5 company-specific changes
fiscal period 2025-12-31
filed 2026-02-12
- Added concrete 2025 examples: federal government shutdown forcing schedule reductions across ~40 airports and EWR ATC/staffing disruptions causing delays and cancellations, demonstrating materialized operational risks with quantified impact.
- Removal of detailed pilot shortage discussion and mitigation costs. Prior year emphasized acute pilot scarcity, regulatory impacts, and required financial support to regional carriers. Current version omits these substantive operational and financial risks.
See the full detail →
5 company-specific changes
fiscal period 2025-12-31
filed 2026-02-12
- New disclosure of $7.2B outpatient portfolio divestiture with material execution and market risks. Substantive strategic transaction requiring investor awareness.
- New disclosure of divestiture risk materially affecting financial condition, results, or cash flows. Represents newly escalated strategic risk.
See the full detail →
4 company-specific changes
fiscal period 2025-12-31
filed 2026-02-12
- Company received March 2025 FDA warning letter citing manufacturing and quality management deficiencies. Specific regulatory enforcement action materially escalates compliance risk and potential operational impact.
- New disclosure of FDA guidance broadening "general wellness devices" and large competitors entering CGM space, escalating competitive threat.
See the full detail →
4 company-specific changes
fiscal period 2025-12-31
filed 2026-02-12
- New disclosure of U.S. federal government contracting risks: uncapped liability, debarment, compliance requirements, and payment disruption from shutdowns.
- Total debt increased 67% ($3.6B to $6.0B) and interest expense rose 11% ($440M to $490M). Removal of interest coverage ratio covenant requirement also noted.
See the full detail →
8 company-specific changes
fiscal period 2025-12-31
filed 2026-02-12
- Material increase in debt ($7.6B) from transaction financing. Reduces financial flexibility and materially increases interest expense burden on cash resources.
- New material acquisition risk disclosure. Warns of potential failure to realize synergies, integration disruption, and tax asset limitations—substantive risks a reasonable investor would consider in evaluating the transaction.
See the full detail →
3 company-specific changes
fiscal period 2025-12-31
filed 2026-02-12
- VMS business divested and Flawless/Spinbrush/Waterpik showerhead exited by end 2025, reducing brand reputation risk exposure from underperforming assets.
- Added specific 2025 divestitures (Flawless, Spinbrush, Waterpik showerhead, VMS business) and new impairment risk language. Concrete execution of previously disclosed risks now materialized.
See the full detail →
9 company-specific changes
fiscal period 2025-12-31
filed 2026-02-12
- New disclosure of material liquidity risk: inability to fund convertible note conversions/repurchases could trigger cross-defaults and cascade debt acceleration, threatening solvency.
- Antibacterials revenue declined 25% ($950M to $713M), reflecting realized impact of regulatory restrictions and consumer preferences on a material revenue stream.
See the full detail →
10 company-specific changes
fiscal period 2025-12-31
filed 2026-02-12
- Material M&A risk: ~280M share issuance causing significant dilution, EPS accretion delay, and reduced shareholder control. Merger-specific governance and valuation risk.
- New disclosure of material merger risk: pending transaction with Kenvue subject to regulatory approval, closing conditions, and termination rights through November 2026. Substantive strategic uncertainty.
See the full detail →
3 company-specific changes
fiscal period 2025-12-31
filed 2026-02-12
- New specific regulatory restrictions disclosed: pricing methodologies, fee restrictions, stored property sale procedures, marketing restrictions, zoning. Escalates from hypothetical future risk to documented current constraints.
- Google customer sourcing decreased from ~67% to >50%, reducing dependence on single channel and associated competitive risk.
See the full detail →
1 company-specific change
fiscal period 2025-12-31
filed 2026-02-12
- Outstanding debt increased from $3.5B to $3.9B (+11%), and commercial paper program newly disclosed, indicating increased leverage and financing complexity.
See the full detail →
7 company-specific changes
fiscal period 2025-12-31
filed 2026-02-12
- New disclosure of digital assets regulatory uncertainty and competitive risk from less-regulated entrants in tokenized securities and synthetic assets.
- SEC fee rule petition denied; exemptive relief expires November 2026. New risks from digital assets, tokenization, prediction market regulation added.
See the full detail →
19 company-specific changes
fiscal period 2025-12-31
filed 2026-02-12
- Debt reduced from $13.13B to $9.48B (28% decrease). However, new risks emerged: pension funding obligations, dividend cut, specific 2026 net leverage target deadline, and explicit investment-grade rating downgrade risk.
- New disclosure of material supply chain disruptions causing production delays, cost increases, inventory buildup, and lost sales. Concrete operational and financial impact.
See the full detail →
13 company-specific changes
fiscal period 2025-12-27
filed 2026-02-12
- New disclosure of announced separation plan (paused Feb 2026) with material execution risks: management distraction, employee retention, customer/supplier loss, financial market volatility, and significant costs regardless of completion.
- New disclosure of material separation risks: failure to realize benefits, operational disruptions, increased costs, smaller/less-diversified entities, tax impacts. Substantive strategic risk.
See the full detail →
8 company-specific changes
fiscal period 2025-12-31
filed 2026-02-12
- Newly disclosed major strategic transaction (spin-off into two public companies) with execution risk, timeline uncertainty, and potential failure to achieve intended benefits.
- Newly disclosed proposed separation of Corteva into two independent public companies. Material strategic, operational, financial, and tax risks including management distraction, potential credit rating downgrade, loss of synergies, and potential tax liability if spin-off fails qualification test.
See the full detail →
3 company-specific changes
fiscal period 2025-12-31
filed 2026-02-11
- New government pricing agreements and OBBBA enacted; Pomalyst and Orencia now subject to price controls; free Eliquis to Medicaid materially worsens revenue outlook.
- FDA issued new draft guidance in October 2025 accelerating biosimilar development and minimizing comparative clinical efficacy studies, materially increasing biosimilar competition risk.
See the full detail →
3 company-specific changes
fiscal period 2025-12-31
filed 2026-02-11
- DOT terminated antitrust immunity for Aeroméxico joint venture; wind-down ordered by January 2026. Judicial stay pending appeal creates material uncertainty over strategic partnership viability and asset impairment risk.
- Fuel costs as % of operating expense declined from 19% to 17% year-over-year, and price range narrowed significantly, indicating materially reduced fuel cost pressure.
See the full detail →
7 company-specific changes
fiscal period 2025-12-31
filed 2026-02-11
- Added concrete 2025 example of major aluminum supplier fires disrupting production with ongoing effects. Also added China rare earth export restrictions causing actual production disruptions and cost increases. These specific, realized incidents materially escalate the supply chain risk from theoretical to demonstrated.
- Congress eliminated U.S. EV purchaser tax credits in 2025, materially reducing demand incentives and Ford's competitive positioning in EV market.
See the full detail →
7 company-specific changes
fiscal period 2025-12-31
filed 2026-02-11
- Newly disclosed major strategic transaction (Mobility spin-off) with material execution, market, and shareholder value risks. Significant management distraction and expense exposure.
- Added operational resilience requirements, specific penalty amounts (DPPA $2,500/individual), and explicit enforcement escalation language indicating materially increased regulatory burden and compliance costs.
See the full detail →
6 company-specific changes
fiscal period 2025-12-31
filed 2026-02-11
- Company disclosed $106M JennAir and $381M Maytag trademark impairments in 2024-2025, demonstrating realized impairment risk materialized with substantial charges.
- Actual downgrade to sub-investment-grade by all three major rating agencies in 2025–2026, with documented loss of access to commercial paper and increased borrowing costs. Material adverse impact on liquidity and capital access.
See the full detail →
2 company-specific changes
fiscal period 2025-12-28
filed 2026-02-11
- Newly disclosed planned separation of Orthopaedics business with 18-24 month timeline. Material strategic transaction introducing execution, regulatory, and market risks that could affect shareholder value and company structure.
- New disclosure of planned separation with significant costs and risk of unachieved strategic/financial benefits. Material M&A event with execution and value realization risk.
See the full detail →
3 company-specific changes
fiscal period 2026-01-03
filed 2026-02-11
- Added specific USMCA tariff risk with 2026 review deadline and potential loss of preferential treatment, escalating from generic trade policy language to concrete, time-bound threat.
- U.S. Government revenue concentration increased from 25% to 27%. New disclosure of MV-75 program as significant, growing portion of revenues with material adverse effect risk if funding delayed.
See the full detail →
3 company-specific changes
fiscal period 2025-12-31
filed 2026-02-11
- Added specific German tax audit (2010-2017) with material exposure, interest, penalties, and litigation risk. Concrete example escalates generic tax risk to substantive disclosed liability.
- Prior year disclosed ongoing SEC/DOJ investigations with potentially significant impact. This year reports both agencies closed inquiries, substantially reducing regulatory risk exposure.
See the full detail →
4 company-specific changes
fiscal period 2025-12-31
filed 2026-02-11
- Added specific $256M goodwill impairment charge for Empire City reporting unit in 2025, plus new trigger "changes in business strategy." Concrete impairment materialized.
- New NY gaming licenses for three integrated resorts with live-dealer tables threaten Northeast operations. Illegal iGaming/sports betting and prediction markets added as emerging competitive threats.
See the full detail →
3 company-specific changes
fiscal period 2025-12-31
filed 2026-02-11
- Revised disclosure significantly expands risk specificity: adds construction delays, supply chain disruptions, labor availability, permit delays, NGO/community opposition, litigation risk, reputational harm, and foreign regulatory/political risks. Materially more detailed risk articulation.
- Shift from optional U.K. tonnage tax to "substantially all ships" operating under it from 2026, plus explicit Global Minimum Tax impact language. Materially escalates tax exposure.
See the full detail →
2 company-specific changes
fiscal period 2025-12-31
filed 2026-02-11
- New disclosure of planned Refining Solutions divestiture with material risks and uncertainties. Introduces significant strategic and operational risks from discontinuation and ongoing minority stake.
- New disclosure of brine extraction limits and early warning plan risks at Chilean facilities—a material operational constraint not previously disclosed.
See the full detail →
10 company-specific changes
fiscal period 2025-12-31
filed 2026-02-11
- New disclosure of material supplier concentration risk and documented supply chain disruptions. September 2024 weather event caused production halt, increased costs, and slowed business growth—concrete evidence of realized risk impact.
- New disclosure of material international expansion with explicit risks: political instability, armed conflict, terrorism, currency volatility, regulatory complexity, FCPA compliance, and potential asset impairments. Substantive new risk exposure.
See the full detail →
10 company-specific changes
fiscal period 2025-12-31
filed 2026-02-11
- SEC investigation concluded with no enforcement action; NDCA expects no further action. Material risk reduction from prior year's ongoing investigations.
- Debt increased 21% ($17.6B to $21.4B); company announced need for additional debt; new language on market volatility and refinancing risk; cash declined.
See the full detail →
1 company-specific change
fiscal period 2025-12-31
filed 2026-02-11
- China exposure increased from 22% to 16% of sales but long-lived assets in China jumped from 29% to 37%, signaling material capital concentration risk amid escalating tariffs and trade uncertainty.
See the full detail →
13 company-specific changes
fiscal period 2025-12-31
filed 2026-02-11
- New disclosure of significant additional financing needs for data center infrastructure, debt/equity issuance, refinancing risk, credit rating pressure, and capital market access constraints.
- New material customer concentration risk: ADS contract equals all existing NIPSCO generating capacity; termination rights, capacity reduction option, and capped reimbursement create significant earnings and asset recovery risk.
See the full detail →
3 company-specific changes
fiscal period 2025-12-31
filed 2026-02-11
- Brazil enacted new regulation requiring PSOs to extend responsibility for merchant settlement integrity, increasing regulatory burden and operational complexity with potential financial impact.
- Mastercard Foundation's voting stake decreased from 9.4% to >5%, materially reducing its blocking power over corporate actions and acquisitions.
See the full detail →
6 company-specific changes
fiscal period 2025-12-31
filed 2026-02-11
- CEO transition and enterprise-wide restructurings newly disclosed. Material governance and execution risk requiring effective management of leadership changes and organizational restructuring.
- Company completed material UScellular Acquisition (August 2025) and disclosed specific integration risks over two-year period, including service disruptions and customer migration challenges. This is a substantive new transaction risk.
See the full detail →
2 company-specific changes
fiscal period 2025-12-31
filed 2026-02-11
- Total indebtedness increased 11.6% from $11.2B to $12.5B year-over-year, materially worsening leverage and debt burden.
- U.S. unionization increased from 40% to 45%, escalating labor cost and disruption risk. Removal of 2024 strike reference softens disclosure slightly but net change worsens exposure.
See the full detail →
3 company-specific changes
fiscal period 2025-12-31
filed 2026-02-10
- New disclosure of deregulation risk to emissions/environmental standards threatens substantial R&D investments, product roadmaps, and competitive positioning. Potential asset impairments and stranded costs.
- Expanded risk disclosure: added execution risk on energy transition strategy, competitive timing risk, capital access risk tied to ESG funding shifts, and dual-scenario downside (faster or slower transition). Materially broadens risk scope.
See the full detail →
10 company-specific changes
fiscal period 2025-12-31
filed 2026-02-10
- New disclosure of significant customer concentration: top 10 customers represent 66% of projected revenues. Material revenue and credit risk newly articulated.
- Debt increased 15% ($3.3B to $3.8B), $550M redemption due Jan 2026, and $3.3B capital commitments planned over five years materially increase refinancing and liquidity risk.
See the full detail →
2 company-specific changes
fiscal period 2025-12-31
filed 2026-02-10
- Added specific disclosure of significantly higher costs from China/international duties and tariffs, particularly in Plumbing Products segment, escalating from generic tariff language to quantified impact.
- Expanded exclusivity commitments to Home Depot now include Kilz primer across multiple channels and geographies, materially restricting product distribution flexibility and increasing competitive constraints.
See the full detail →
6 company-specific changes
fiscal period 2025-12-31
filed 2026-02-10
- Company recorded $919M in premium deficiency reserves in 2025 (Q1 and Q2) versus $1.1B in Q3 2024, but now recurring across multiple quarters and product lines, signaling ongoing underpricing and claims deterioration.
- New disclosure of state legislative activity prohibiting PBM-pharmacy affiliation. Material regulatory risk to core vertical integration strategy and business model.
See the full detail →
4 company-specific changes
fiscal period 2025-12-31
filed 2026-02-10
- New disclosure of DOE emergency orders requiring continued J.H. Campbell operation with uncertain cost recovery at FERC and MPSC, plus unquantified impact of executive actions.
- New federal regulatory risk disclosed: FERC's potential assertion of jurisdiction over distribution interconnections and direct wholesale purchasing by large customers. Escalates competitive and revenue pressure beyond existing ROA concerns.
See the full detail →
4 company-specific changes
fiscal period 2025-12-31
filed 2026-02-10
- Significant escalation in generic competition threats. JAKAFI now faces six generic manufacturers (vs. one Apotex ANDA previously); OPZELURA faces four (vs. one Padagis). Multiple new patent challenges and litigation increase exclusivity risk materially.
- New disclosure: JAKAFI revenues comprise substantial majority of total revenues and will decline when patent exclusivity expires in 2028. Material revenue concentration and cliff risk.
See the full detail →
3 company-specific changes
fiscal period 2025-12-31
filed 2026-02-10
- New disclosure of AI-driven intermediary threat to distribution, brand loyalty, and loyalty program—a substantive escalation of competitive risk beyond prior generic intermediary concerns.
- New disclosure of regulatory risk to credit card issuers/networks impacting co-branded card revenues and loyalty program funding—a material revenue and program sustainability concern.
See the full detail →